Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
Yen‐Chieh Lee, Chin‐Hsien Lin, Ruey‐Meei Wu, et al.
PLoS ONE (2014) Vol. 9, Iss. 6, pp. e98961-e98961
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio, Michael A. Schwarzschild
The Lancet Neurology (2016) Vol. 15, Iss. 12, pp. 1257-1272
Closed Access | Times Cited: 1554
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 901
Epidemiology of Parkinson's disease
Alexis Elbaz, Laure Carcaillon‐Bentata, Sofiane Kab, et al.
Revue Neurologique (2015) Vol. 172, Iss. 1, pp. 14-26
Closed Access | Times Cited: 368
Determinants of dopaminergic neuron loss in Parkinson's disease
D. James Surmeier
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3657-3668
Open Access | Times Cited: 338
Calcium and Parkinson's disease
D. James Surmeier, Paul T. Schumacker, Jaime Díaz Guzmán, et al.
Biochemical and Biophysical Research Communications (2016) Vol. 483, Iss. 4, pp. 1013-1019
Open Access | Times Cited: 181
Parkinson's Disease Is Not Simply a Prion Disorder
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Journal of Neuroscience (2017) Vol. 37, Iss. 41, pp. 9799-9807
Open Access | Times Cited: 167
The role of Ca2+ signaling in Parkinson's disease
Sofia Zaichick, Kaitlyn M. McGrath, Gabriela Caraveo
Disease Models & Mechanisms (2017) Vol. 10, Iss. 5, pp. 519-535
Open Access | Times Cited: 166
Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress
Jaime N. Guzmán, Ema Ilijić, Ben Yang, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 6, pp. 2266-2280
Open Access | Times Cited: 125
Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing
Farah H. Siddiqi, Fiona M. Menzies, Ana López, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 113
Risk of Parkinson's disease following severe constipation: A nationwide population-based cohort study
Chin‐Hsien Lin, Jou‐Wei Lin, Yingchun Liu, et al.
Parkinsonism & Related Disorders (2014) Vol. 20, Iss. 12, pp. 1371-1375
Closed Access | Times Cited: 108
The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease
Birgit Liss, Jörg Striessnig
The Annual Review of Pharmacology and Toxicology (2019) Vol. 59, Iss. 1, pp. 263-289
Closed Access | Times Cited: 95
L-type calcium channels as drug targets in CNS disorders
Nadine J. Ortner, Jörg Striessnig
Channels (2015) Vol. 10, Iss. 1, pp. 7-13
Open Access | Times Cited: 93
Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study
Huei‐Kai Huang, Jen‐Hung Wang, Wei‐Yi Lei, et al.
Parkinsonism & Related Disorders (2017) Vol. 47, pp. 26-31
Closed Access | Times Cited: 90
Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons
Enrico Zampese, David L. Wokosin, Patricia González‐Rodríguez, et al.
Science Advances (2022) Vol. 8, Iss. 39
Open Access | Times Cited: 49
Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study
Youngkwon Jo, Seungyeon Kim, Byoung Seok Ye, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease
D. James Surmeier, Glenda M. Halliday, Tanya Simuni
Experimental Neurology (2017) Vol. 298, pp. 202-209
Open Access | Times Cited: 80
Beneficial effects of Angiotensin II receptor blockers in brain disorders
Juan M. Saavedra
Pharmacological Research (2017) Vol. 125, pp. 91-103
Closed Access | Times Cited: 74
Hypertension and Diagnosis of Parkinson’s Disease: A Meta-Analysis of Cohort Studies
Liyan Hou, Qiujuan Li, Liping Jiang, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 67
Calcium, Bioenergetics, and Parkinson’s Disease
Enrico Zampese, D. James Surmeier
Cells (2020) Vol. 9, Iss. 9, pp. 2045-2045
Open Access | Times Cited: 63
Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders
Lucy Colbourne, Paul J. Harrison
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3904-3912
Open Access | Times Cited: 36
The role of the brain renin-angiotensin system in Parkinson´s disease
José L. Labandeira‐García, Carmen M. Labandeira, María J. Guerra, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Loss of angiotensin II receptor expression in dopamine neurons in Parkinson’s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation
W. Michael Zawada, Robert E. Mrak, JoAnn Biedermann, et al.
Acta Neuropathologica Communications (2015) Vol. 3, Iss. 1
Open Access | Times Cited: 60
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
Santiago Pérez-Lloret, Matilde Otero‐Losada, Jorge E. Toblli, et al.
Expert Opinion on Investigational Drugs (2017) Vol. 26, Iss. 10, pp. 1163-1173
Open Access | Times Cited: 58
Risk of Parkinson's disease following anxiety disorders: a nationwide population‐based cohort study
Chin‐Hsien Lin, Jou‐Wei Lin, Yen‐Chen Liu, et al.
European Journal of Neurology (2015) Vol. 22, Iss. 9, pp. 1280-1287
Closed Access | Times Cited: 53
Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system
Ursula Quitterer, Said AbdAlla
Pharmacological Research (2019) Vol. 154, pp. 104230-104230
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top